Parkinson. Parkinson disease, Incl: Hemiparkinsonism, Paralysis agitans Parkinsonism or Parkinson disease: NOS, idiopathic, primary
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria:All of the patients should be in stage 2 or 3 of Parkinson disease based on Hoehn and Yahr criteria and also should: be under stable pharmacological treatment regime at least 30 days before entrance in study; be in stable clinical condition to complete the study; have appropriate primary response to Levo-DOPA or it's agonist; not have Parkinson related dementia; not have abnormal MRI; not have drug related parkinsonism. Exclusion criteria: patient unwillingness to complete the study; patient inability to complete the study because of any reason at any time during the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Balance. Timepoint: Before, just after 8 sessions of trans cranial direct current stimulation plus occupational therapy and 3 months later. Method of measurement: Berge-Balance questionnare.;Sleep quality. Timepoint: Before, just after 8 sessions of trans cranial direct current stimulation plus occupational therapy and 3 months later. Method of measurement: Epworth questionnaire.;Life quality. Timepoint: Before, just after 8 sessions of trans cranial direct current stimulation plus occupational therapy and 3 months later. Method of measurement: EQ-D5 questionnaire.;Tiredness. Timepoint: Before, just after 8 sessions of trans cranial direct current stimulation plus occupational therapy and 3 months later. Method of measurement: Fatigue severity scale questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: During and just after each session of trans cranial direct current stimulation performance. Method of measurement: Asking from a patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Firoozgar hospital